Effect of fructose and its epimers on postprandial carbohydrate metabolism: A systematic review and meta-analysis
- PMID: 32220498
- DOI: 10.1016/j.clnu.2020.03.002
Effect of fructose and its epimers on postprandial carbohydrate metabolism: A systematic review and meta-analysis
Abstract
Aims: To synthesize the evidence of the effect of small doses (≤30-g/meal) of fructose and its epimers (allulose, tagatose, and sorbose) on the postprandial glucose and insulin response to carbohydrate-containing meals.
Methods: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials were searched through to April 9, 2019. We included randomized (RCTs) and non-randomized acute, single-meal, controlled feeding trials that added ≤30-g of fructose or its epimers either prior to or with a carbohydrate-containing meal compared with the same meal alone. Outcomes included the incremental area under the curve (iAUC) for glucose and insulin, the Matsuda Insulin Sensitivity Index, and the Early Insulin Secretion Index. Data were expressed as ratio of means (RoM) with 95% CIs and pooled using the inverse variance method. The overall certainty of the evidence was evaluated using GRADE.
Results: Forty trial comparisons (n = 400) were included (none for sorbose). Allulose significantly reduced the postprandial iAUC glucose response by 10% (0.90 [0.84 to 0.96], P < 0.01). Tagatose significantly reduced the postprandial iAUC insulin response by 25% (0.75 [0.62 to 0.91], P < 0.01) and showed a non-significant 3% reduction in the postprandial iAUC glucose response (0.97 [0.94 to 1.00], P = 0.07). There was no effect of fructose on any outcome. The certainty of the evidence was graded as low to moderate for fructose, moderate for allulose, and low for tagatose.
Conclusions: Small doses of allulose and tagatose, but not fructose, lead to modest improvements on postprandial glucose and insulin regulation. There is a need for long-term RCTs to confirm the sustainability of these improvements.
Keywords: Allulose; Diabetes; Fructose; Meta-analysis; Postprandial carbohydrate metabolism.
Copyright © 2020. Published by Elsevier Ltd.
Conflict of interest statement
Conflict of Interest CRB and JCN have worked as clinical research coordinators at INQUIS Clinical Research (formerly known as GI Labs). TAK has received research support from the Canadian Institutes of Health Research (CIHR) and an unrestricted travel donation from Bee Maid Honey Ltd. He was an invited speaker at a Calorie Control Council annual general meeting for which he received an honorarium. TMSW is a part owner and the President of INQUIS Clinical Research (formerly known as GI Labs). He has received consultant fees, honoraria, travel funding, or served on the scientific advisory board for CIHR, Diabetes Canada, Temasek Polytechnic (Singapore), University of Arizona and the DNSG of the EASD. CWCK has received grants or research support from the Advanced Food Materials Network, Agriculture and Agri-Foods Canada (AAFC), Almond Board of California, American Pistachio Growers, Barilla, Calorie Control Council, Canadian Institutes of Health Research (CIHR), Canola Council of Canada, International Nut and Dried Fruit Council, International Tree Nut Council Research and Education Foundation, Loblaw Brands Ltd, Pulse Canada, Saskatchewan Pulse Growers and Unilever. He has received in-kind research support from the Almond Board of California, American Peanut Council, Barilla, California Walnut Commission, Kellogg Canada, Loblaw Companies, Quaker (Pepsico), Primo, Unico, Unilever, WhiteWave Foods. He has received travel support and/or honoraria from the American Peanut Council, American Pistachio Growers, Barilla, California Walnut Commission, Canola Council of Canada, General Mills, International Nut and Dried Fruit Council, International Pasta Organization, Loblaw Brands Ltd, Nutrition Foundation of Italy, Oldways Preservation Trust, Paramount Farms, Peanut Institute, Pulse Canada, Sabra Dipping Co., Saskatchewan Pulse Growers, Sun-Maid, Tate & Lyle, Unilever and White Wave Foods. He has served on the scientific advisory board for the International Tree Nut Council, International Pasta Organization, McCormick Science Institute, Oldways Preservation Trust, Paramount Farms and Pulse Canada. He is a member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the European Association for the Study of Diabetes (EASD), is on the Clinical Practice Guidelines Expert Committee for Nutrition Therapy of the EASD and is a Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. JLS has received research support from the Canadian Foundation for Innovation, Ontario Research Fund, Province of Ontario Ministry of Research and Innovation and Science, Canadian Institutes of health Research (CIHR), Diabetes Canada, PSI Foundation, Banting and Best Diabetes Centre (BBDC), American Society for Nutrition (ASN), INC International Nut and Dried Fruit Council Foundation, National Dried Fruit Trade Association, The Tate and Lyle Nutritional Research Fund at the University of Toronto, The Glycemic Control and Cardiovascular Disease in Type 2 Diabetes Fund at the University of Toronto (a fund established by the Alberta Pulse Growers), and the Nutrition Trialists Fund at the University of Toronto (a fund established by an inaugural donation from the Calorie Control Council). He has received in-kind food donations to support a randomized controlled trial from the Almond Board of California, California Walnut Commission, American Peanut Council, Barilla, Unilever, Unico/Primo, Loblaw Companies, Quaker, Kellogg Canada, and WhiteWave Foods. He has received travel support, speaker fees and/or honoraria from Diabetes Canada, Mott's LLP, Dairy Farmers of Canada, FoodMinds LLC, International Sweeteners Association, Nestlé, Pulse Canada, Canadian Society for Endocrinology and Metabolism (CSEM), GI Foundation, Abbott, Biofortis, ASN, Northern Ontario School of Medicine, INC Nutrition Research & Education Foundation, European Food Safety Authority (EFSA), and Physicians Committee for Responsible Medicine. He has or has had ad hoc consulting arrangements with Perkins Coie LLP, Tate & Lyle, and Wirtschaftliche Vereinigung Zucker e.V. He is a member of the European Fruit Juice Association Scientific Expert Panel. He is on the Clinical Practice Guidelines Expert Committees of Diabetes Canada, European Association for the study of Diabetes (EASD), Canadian Cardiovascular Society (CCS), and Obesity Canada. He serves or has served as an unpaid scientific advisor for the Food, Nutrition, and Safety Program (FNSP) and the Technical Committee on Carbohydrates of the International Life Science Institute (ILSI) North America. He is a member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the EASD, and Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. His wife is an employee of Sobeys Inc. No other potential conflicts of interest relevant to this article were reported.
Similar articles
-
The Effect of Small Doses of Fructose and Its Epimers on Glycemic Control: A Systematic Review and Meta-Analysis of Controlled Feeding Trials.Nutrients. 2018 Nov 20;10(11):1805. doi: 10.3390/nu10111805. Nutrients. 2018. PMID: 30463314 Free PMC article.
-
The effect of small doses of fructose and allulose on postprandial glucose metabolism in type 2 diabetes: A double-blind, randomized, controlled, acute feeding, equivalence trial.Diabetes Obes Metab. 2018 Oct;20(10):2361-2370. doi: 10.1111/dom.13374. Epub 2018 Jun 25. Diabetes Obes Metab. 2018. PMID: 29797503 Free PMC article. Clinical Trial.
-
A Double-Blind, Randomized Controlled, Acute Feeding Equivalence Trial of Small, Catalytic Doses of Fructose and Allulose on Postprandial Blood Glucose Metabolism in Healthy Participants: The Fructose and Allulose Catalytic Effects (FACE) Trial.Nutrients. 2018 Jun 9;10(6):750. doi: 10.3390/nu10060750. Nutrients. 2018. PMID: 29890724 Free PMC article. Clinical Trial.
-
Change in postprandial substrate oxidation after a high-fructose meal is related to body mass index in healthy men.Nutr Res. 2013 Jun;33(6):435-41. doi: 10.1016/j.nutres.2013.03.007. Epub 2013 Apr 30. Nutr Res. 2013. PMID: 23746558 Free PMC article. Clinical Trial.
-
Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus.Cochrane Database Syst Rev. 2019 Nov 12;2019(11). doi: 10.1002/14651858.CD006133.pub5. Cochrane Database Syst Rev. 2019. PMID: 31711271
Cited by
-
Chronic Fructose Substitution for Glucose or Sucrose in Food or Beverages and Metabolic Outcomes: An Updated Systematic Review and Meta-Analysis.Front Nutr. 2021 Apr 28;8:647600. doi: 10.3389/fnut.2021.647600. eCollection 2021. Front Nutr. 2021. PMID: 33996873 Free PMC article.
-
Effect of fruit on glucose control in diabetes mellitus: a meta-analysis of nineteen randomized controlled trials.Front Endocrinol (Lausanne). 2023 May 5;14:1174545. doi: 10.3389/fendo.2023.1174545. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37214237 Free PMC article. Review.
-
Allulose for the attenuation of postprandial blood glucose levels in healthy humans: A systematic review and meta-analysis.PLoS One. 2023 Apr 6;18(4):e0281150. doi: 10.1371/journal.pone.0281150. eCollection 2023. PLoS One. 2023. PMID: 37023000 Free PMC article.
-
Dietary fructose and risk of metabolic syndrome in Chinese residents aged 45 and above: results from the China National Nutrition and Health Survey.Nutr J. 2021 Oct 3;20(1):83. doi: 10.1186/s12937-021-00739-9. Nutr J. 2021. PMID: 34602079 Free PMC article.
-
A pilot study on the effect of D-allulose on postprandial glucose levels in patients with type 2 diabetes mellitus during Ramadan fasting.Diabetol Metab Syndr. 2022 Jun 21;14(1):86. doi: 10.1186/s13098-022-00856-3. Diabetol Metab Syndr. 2022. PMID: 35729673 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous